A new three-dimensional ultrasound microimaging technology for preclinical studies using a transgenic prostate cancer mouse model

Cancer Research

Volumn 65, Issue 14, 2005, Pages 6337-6345

  Wirtzfeld, Lauren A ^a,b   Wu, Guojun ^a   Bygrave, Michael ^b   Yamasaki, Yasuto ^a,c   Sakai, Hideki ^c   Moussa, Madeleine ^a   Izawa, Jonathan I ^a   Downey, Dónal B ^a,b   Greenberg, Norman M ^d   Fenster, Aaron ^a,b   Xuan, Jim W ^a,e   Lacefield, James C ^a,b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b ROBARTS RESEARCH INSTITUTE   (Canada)

^c NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d Fred Hutchinson Cancer Research Center   (United States)

^e LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATIC SECRETORY PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CONTROLLED STUDY; CORRELATION COEFFICIENT; ECHOGRAPHY; GENETIC ENGINEERING; HISTOLOGY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; QUALITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; THREE DIMENSIONAL IMAGING; TRANSGENIC MOUSE; TREATMENT OUTCOME; TUMOR VOLUME;

ADENOCARCINOMA; ANIMALS; DISEASE MODELS, ANIMAL; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; MICE, TRANSGENIC; PROSTATIC NEOPLASMS; SENSITIVITY AND SPECIFICITY;

EID: 22244491316     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-05-0414     Document Type: Article

References (22)

1. Greenberg NM, Demayo F, Finegold MJ. et al. Prostate cancer in a transgenic mouse. Proc Natl Acad Sci U S A 1995;92:3439-43.
2. Masumori N, Thomas TZ, Chaurand P, et al. A probasin-large T antigen transgenic mouse line develops prostate adenocarcinoma and neuroendocrine carcinoma with metastatic potential. Cancer Res 2001;61:2239-49.
3. Abate-Shen C, Shen MM. Mouse models of prostate carcinogenesis. Trends Genet 2002;18:S1-5.
4. Huss WJ, Maddison LA, Greenberg NM. Autochthonous mouse models for prostate cancer: past, present and future. Semin Cancer Biol 2001;11:245-60.
5. Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000;92:205-16.
6. Weissleder R. Scaling down imaging: molecular mapping of cancer in mice. Nat Rev Cancer 2002;2:1-8.
7. Hsu CX, Ross BD, Chrisp CE, et al. Longitudinal cohort analysis of lethal prostate cancer progression in transgenic mice. J Urol 1998;160:1500-5.
8. Adams JY, Johnson M, Sato M, et al. Visualization of advanced human prostate cancer lesions in living mice by a targeted gene transfer vector and optical imaging. Nat Med 2002;8:891-7.
9. Lyons SK, Meuwissen R, Krimpenfort P, Berns A. The generation of a conditional reporter that enables bioluminescence imaging of Cre/loxP-dependent tumorigenesis in mice. Cancer Res 2003;63:7042-6.
10. Xie X, Luo Z, Slawin KM, Spencer DM. The EZC-prostate model: noninvasive prostate imaging in living mice. Mol Endocrinol 2004;18:722-32.
11. Turnbull DH, Ramsay JA, Shivji GS, et al. Ultrasound backscatter microscope analysis of mouse melanoma progression. Ultrasound Med Biol 1996;22:845-53.
12. Gabril MY, Onita T, Ji PG, et al. Prostate targeting: PSP94 gene promoter/enhancer region directed prostate tissue-specific expression in a transgenic mouse prostate cancer model. Gene Ther 2002;9:1589-99.
13. Duan WM, Gabril MY, Moussa M, et al. Knock-in of SV40 Tag oncogene in a mouse adenocarcinoma of the prostate (KIMAP) model demonstrates advantageous features over the transgenic model. Oncogene 2005;24:1510-24.
14. Gabril MY, Duan WM, Wu GJ, et al. A novel knock-in prostate cancer model demonstrates biology similar to that of human prostate cancer and suitable for preclinical studies. Mol Ther 2005;11:348-62.
15. Foster FS, Zhang MY, Zhou YQ, et al, A new ultrasound instrument for in vivo microimaging of mice. Ultrasound Med Biol 2002;28:1165-72.
16. Fenster A, Downey DB, Cardinal HN, Three-dimensional ultrasound imaging. Phys Med Biol 2001;46: R67-99.
17. Shapiro SS, Wilk MB. An analysis of variance test for normality (complete samples). Biometrika 1965;52:591-611.
18. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307-10.
19. Foster FS, Paviin CJ, Harasiewicz KA, Christopher DA, Turnbull DH. Advances in ultrasound biomicroscopy. Ultrasound Med Biol 2000;26:1-27.
20. Klaunberg BA, Lizak MJ. Considerations for setting up a small-animal imaging facility. Lab Anim (NY) 2004;33:28-34.
21. Goertz DE, Yu JL, Kerbel RS, Burns PN, Foster FS. High-frequency Doppler ultrasound monitors the effects of antivascular therapy on tumor blood flow. Cancer Res 2002;62:6371-5.
22. Goertz DE, Cherin E, Needles A, et al. High frequency nonlinear B-scan imaging of microbubble contrast agents. IEEE Trans Ultrason Ferroelectr Freq Control 2005;52:65-79.